Report Detail

Medical Devices & Consumables COVID-19 Impact on Global Biopharmaceutical Buffers Market Insights, Forecast to 2026

  • RnM3990153
  • |
  • 05 June, 2020
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Biopharmaceutical Buffers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical Buffers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Biopharmaceutical Buffers market is segmented into
Sterile Buffer
Non-sterile Buffer

Segment by Application, the Biopharmaceutical Buffers market is segmented into
Recombinant Proteins
Monoclonal Antibodies
Antibiotics
Probiotics
Other

Regional and Country-level Analysis
The Biopharmaceutical Buffers market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biopharmaceutical Buffers market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Biopharmaceutical Buffers Market Share Analysis

Biopharmaceutical Buffers market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Biopharmaceutical Buffers by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Biopharmaceutical Buffers business, the date to enter into the Biopharmaceutical Buffers market, Biopharmaceutical Buffers product introduction, recent developments, etc.
The major vendors covered:
GE Healthcare
Thermo Fisher Scientific
Danaher Corporation
Sartorius StedimBiotech
Merck
Eppendorf
Roche
Nova Biomedicals
Lonza
Becton, and Dickinson and Company


1 Study Coverage

  • 1.1 Biopharmaceutical Buffers Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Biopharmaceutical Buffers Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Biopharmaceutical Buffers Market Size Growth Rate by Type
    • 1.4.2 Sterile Buffer
    • 1.4.3 Non-sterile Buffer
  • 1.5 Market by Application
    • 1.5.1 Global Biopharmaceutical Buffers Market Size Growth Rate by Application
    • 1.5.2 Recombinant Proteins
    • 1.5.3 Monoclonal Antibodies
    • 1.5.4 Antibiotics
    • 1.5.5 Probiotics
    • 1.5.6 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Biopharmaceutical Buffers Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Biopharmaceutical Buffers Industry
      • 1.6.1.1 Biopharmaceutical Buffers Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Biopharmaceutical Buffers Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Biopharmaceutical Buffers Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Biopharmaceutical Buffers Market Size Estimates and Forecasts
    • 2.1.1 Global Biopharmaceutical Buffers Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Biopharmaceutical Buffers Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Biopharmaceutical Buffers Production Estimates and Forecasts 2015-2026
  • 2.2 Global Biopharmaceutical Buffers Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Biopharmaceutical Buffers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Biopharmaceutical Buffers Manufacturers Geographical Distribution
  • 2.4 Key Trends for Biopharmaceutical Buffers Markets & Products
  • 2.5 Primary Interviews with Key Biopharmaceutical Buffers Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Biopharmaceutical Buffers Manufacturers by Production Capacity
    • 3.1.1 Global Top Biopharmaceutical Buffers Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Biopharmaceutical Buffers Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Biopharmaceutical Buffers Manufacturers Market Share by Production
  • 3.2 Global Top Biopharmaceutical Buffers Manufacturers by Revenue
    • 3.2.1 Global Top Biopharmaceutical Buffers Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Biopharmaceutical Buffers Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Biopharmaceutical Buffers Revenue in 2019
  • 3.3 Global Biopharmaceutical Buffers Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical Buffers Production by Regions

  • 4.1 Global Biopharmaceutical Buffers Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Biopharmaceutical Buffers Regions by Production (2015-2020)
    • 4.1.2 Global Top Biopharmaceutical Buffers Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Biopharmaceutical Buffers Production (2015-2020)
    • 4.2.2 North America Biopharmaceutical Buffers Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Biopharmaceutical Buffers Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Biopharmaceutical Buffers Production (2015-2020)
    • 4.3.2 Europe Biopharmaceutical Buffers Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Biopharmaceutical Buffers Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Biopharmaceutical Buffers Production (2015-2020)
    • 4.4.2 China Biopharmaceutical Buffers Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Biopharmaceutical Buffers Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Biopharmaceutical Buffers Production (2015-2020)
    • 4.5.2 Japan Biopharmaceutical Buffers Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Biopharmaceutical Buffers Import & Export (2015-2020)

5 Biopharmaceutical Buffers Consumption by Region

  • 5.1 Global Top Biopharmaceutical Buffers Regions by Consumption
    • 5.1.1 Global Top Biopharmaceutical Buffers Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Biopharmaceutical Buffers Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Biopharmaceutical Buffers Consumption by Application
    • 5.2.2 North America Biopharmaceutical Buffers Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Biopharmaceutical Buffers Consumption by Application
    • 5.3.2 Europe Biopharmaceutical Buffers Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Biopharmaceutical Buffers Consumption by Application
    • 5.4.2 Asia Pacific Biopharmaceutical Buffers Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Biopharmaceutical Buffers Consumption by Application
    • 5.5.2 Central & South America Biopharmaceutical Buffers Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Biopharmaceutical Buffers Consumption by Application
    • 5.6.2 Middle East and Africa Biopharmaceutical Buffers Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Biopharmaceutical Buffers Market Size by Type (2015-2020)
    • 6.1.1 Global Biopharmaceutical Buffers Production by Type (2015-2020)
    • 6.1.2 Global Biopharmaceutical Buffers Revenue by Type (2015-2020)
    • 6.1.3 Biopharmaceutical Buffers Price by Type (2015-2020)
  • 6.2 Global Biopharmaceutical Buffers Market Forecast by Type (2021-2026)
    • 6.2.1 Global Biopharmaceutical Buffers Production Forecast by Type (2021-2026)
    • 6.2.2 Global Biopharmaceutical Buffers Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Biopharmaceutical Buffers Price Forecast by Type (2021-2026)
  • 6.3 Global Biopharmaceutical Buffers Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Biopharmaceutical Buffers Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Biopharmaceutical Buffers Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 GE Healthcare
    • 8.1.1 GE Healthcare Corporation Information
    • 8.1.2 GE Healthcare Overview and Its Total Revenue
    • 8.1.3 GE Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 GE Healthcare Product Description
    • 8.1.5 GE Healthcare Recent Development
  • 8.2 Thermo Fisher Scientific
    • 8.2.1 Thermo Fisher Scientific Corporation Information
    • 8.2.2 Thermo Fisher Scientific Overview and Its Total Revenue
    • 8.2.3 Thermo Fisher Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Thermo Fisher Scientific Product Description
    • 8.2.5 Thermo Fisher Scientific Recent Development
  • 8.3 Danaher Corporation
    • 8.3.1 Danaher Corporation Corporation Information
    • 8.3.2 Danaher Corporation Overview and Its Total Revenue
    • 8.3.3 Danaher Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Danaher Corporation Product Description
    • 8.3.5 Danaher Corporation Recent Development
  • 8.4 Sartorius StedimBiotech
    • 8.4.1 Sartorius StedimBiotech Corporation Information
    • 8.4.2 Sartorius StedimBiotech Overview and Its Total Revenue
    • 8.4.3 Sartorius StedimBiotech Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Sartorius StedimBiotech Product Description
    • 8.4.5 Sartorius StedimBiotech Recent Development
  • 8.5 Merck
    • 8.5.1 Merck Corporation Information
    • 8.5.2 Merck Overview and Its Total Revenue
    • 8.5.3 Merck Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Merck Product Description
    • 8.5.5 Merck Recent Development
  • 8.6 Eppendorf
    • 8.6.1 Eppendorf Corporation Information
    • 8.6.2 Eppendorf Overview and Its Total Revenue
    • 8.6.3 Eppendorf Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Eppendorf Product Description
    • 8.6.5 Eppendorf Recent Development
  • 8.7 Roche
    • 8.7.1 Roche Corporation Information
    • 8.7.2 Roche Overview and Its Total Revenue
    • 8.7.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Roche Product Description
    • 8.7.5 Roche Recent Development
  • 8.8 Nova Biomedicals
    • 8.8.1 Nova Biomedicals Corporation Information
    • 8.8.2 Nova Biomedicals Overview and Its Total Revenue
    • 8.8.3 Nova Biomedicals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Nova Biomedicals Product Description
    • 8.8.5 Nova Biomedicals Recent Development
  • 8.9 Lonza
    • 8.9.1 Lonza Corporation Information
    • 8.9.2 Lonza Overview and Its Total Revenue
    • 8.9.3 Lonza Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 Lonza Product Description
    • 8.9.5 Lonza Recent Development
  • 8.10 Becton, and Dickinson and Company
    • 8.10.1 Becton, and Dickinson and Company Corporation Information
    • 8.10.2 Becton, and Dickinson and Company Overview and Its Total Revenue
    • 8.10.3 Becton, and Dickinson and Company Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 Becton, and Dickinson and Company Product Description
    • 8.10.5 Becton, and Dickinson and Company Recent Development
  • 8.11 GEA
    • 8.11.1 GEA Corporation Information
    • 8.11.2 GEA Overview and Its Total Revenue
    • 8.11.3 GEA Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 GEA Product Description
    • 8.11.5 GEA Recent Development

9 Production Forecasts by Regions

  • 9.1 Global Top Biopharmaceutical Buffers Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Biopharmaceutical Buffers Regions Forecast by Production (2021-2026)
  • 9.3 Key Biopharmaceutical Buffers Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Biopharmaceutical Buffers Consumption Forecast by Region

  • 10.1 Global Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
  • 10.2 North America Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Biopharmaceutical Buffers Sales Channels
    • 11.2.2 Biopharmaceutical Buffers Distributors
  • 11.3 Biopharmaceutical Buffers Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Market Opportunities and Drivers
  • 12.2 Market Challenges
  • 12.3 Market Risks/Restraints
  • 12.4 Porter's Five Forces Analysis

13 Key Finding in The Global Biopharmaceutical Buffers Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Biopharmaceutical Buffers. Industry analysis & Market Report on COVID-19 Impact on Global Biopharmaceutical Buffers is a syndicated market report, published as COVID-19 Impact on Global Biopharmaceutical Buffers Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Biopharmaceutical Buffers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,787.70
    5,681.55
    7,575.40
    4,561.90
    6,842.85
    9,123.80
    748,181.00
    1,122,271.50
    1,496,362.00
    413,560.00
    620,340.00
    827,120.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report